|
Development and validation of blood-based predictive biomarkers for response to PD-(L)-1 checkpoint inhibitors: Evidence of a universal systemic core of 3D immunogenetic profiling across multiple oncological indications. |
|
|
Employment - Oxford Biodynamics |
Leadership - Oxford Biodynamics |
Stock and Other Ownership Interests - Oxford Biodynamics |
Patents, Royalties, Other Intellectual Property - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
Patents, Royalties, Other Intellectual Property - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
Leadership - Oxford Biodynamics |
Stock and Other Ownership Interests - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
Leadership - Oxford Biodynamics |
Stock and Other Ownership Interests - Oxford Biodynamics |
Patents, Royalties, Other Intellectual Property - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
|
|
Employment - Oxford Biodynamics |
Leadership - Oxford Biodynamics |
|
|
Employment - Advanced Pathology Associates |
Consulting or Advisory Role - Oxford Biodynamics |
|
|
No Relationships to Disclose |